[HTML][HTML] Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to …
…, D Aust, C Bassi, V Berger, E Chamorey… - European journal of …, 2014 - Elsevier
Background Using potential surrogate end-points for overall survival (OS) such as Disease-Free-
(DFS) or Progression-Free Survival (PFS) is increasingly common in randomised …
(DFS) or Progression-Free Survival (PFS) is increasingly common in randomised …
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival
…, P Hofman, SK Parks, E Chamorey… - Critical reviews in …, 2012 - Elsevier
Prostate-specific antigen (PSA) levels in blood are widely used in prostate cancer (PCa) for
the management of this disease at every stage of progression. Currently, PSA levels …
the management of this disease at every stage of progression. Currently, PSA levels …
HIF‐1α and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome
…, F Ettore, A Ramaioli, E Chamorey… - … journal of cancer, 2007 - Wiley Online Library
Hypoxia stabilizes HIF‐1α (Hypoxia Inducible Factor‐1α), which then triggers the expression
of several genes involved in many aspects of cancer progression, including metabolic …
of several genes involved in many aspects of cancer progression, including metabolic …
Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA
G Milano, J Gal, A Creisson, E Chamorey - Future Virology, 2022 - Future Medicine
While tolerance to COVID-19 vaccination is considered satisfactory, a phenomenon of
myocarditis, although rare, is becoming a safety concern in mRNA COVID-19 vaccination. The …
myocarditis, although rare, is becoming a safety concern in mRNA COVID-19 vaccination. The …
[HTML][HTML] Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
…, B Bailly-Maitre, B Verrière, E Chamorey… - Nature …, 2022 - nature.com
Patients with hematological malignancies have impaired immune response after two doses
of BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2. Here, in this observational …
of BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2. Here, in this observational …
Head and neck reconstruction with free flaps: a report on 213 cases
O Dassonville, G Poissonnet, E Chamorey… - European Archives of …, 2008 - Springer
The aim of this retrospective study is to review the experience of our institution in performing
microvascular head and neck reconstruction between 2000 and 2004. During this period, …
microvascular head and neck reconstruction between 2000 and 2004. During this period, …
French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable …
…, F Peyrade, PY Marcy, E Chamorey… - International Journal of …, 2006 - Elsevier
Background: Unresectable carcinomas of the oropharynx and hypopharynx still have a poor
long-term prognosis. Following a previous phase II study, this phase III multicenter trial was …
long-term prognosis. Following a previous phase II study, this phase III multicenter trial was …
[PDF][PDF] Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and …
…, P Formento, N Renée, E Chamorey… - Journal of clinical …, 2002 - Citeseer
Purpose: The aim of this multicenter prospective study was to evaluate the role of intratumoral
parameters related to fluorouracil (FU) sensitivity in 103 metastatic colorectal cancer …
parameters related to fluorouracil (FU) sensitivity in 103 metastatic colorectal cancer …
[HTML][HTML] New advances in DPYD genotype and risk of severe toxicity under capecitabine
…, V Servent, N Dohollou, Y Château, E Chamorey… - PLoS …, 2017 - journals.plos.org
Background Deficiency in dihydropyrimidine dehydrogenase (DPD) enzyme is the main
cause of severe and lethal fluoropyrimidine-related toxicity. Various approaches have been …
cause of severe and lethal fluoropyrimidine-related toxicity. Various approaches have been …
The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma
…, M Boncompagni, D Ambrosetti, E Chamorey… - Cancer research, 2014 - AACR
Mutations in the von Hippel–Lindau gene upregulate expression of the central angiogenic
factor VEGF, which drives abnormal angiogenesis in clear cell renal cell carcinomas (ccRCC). …
factor VEGF, which drives abnormal angiogenesis in clear cell renal cell carcinomas (ccRCC). …